Focal Tumour Ablation: Early-stage Primary Lung Cancer and Lung Metastases
To provide a systematic literature review that will be one of the six components of the Recommendation Report of the Interventional Oncology Steering Committee (other components will include demand forecasting, costing analysis, jurisdictional review, system capacity, literature review, and current state, summary available at www.cancercare.on.ca/fta.)
Patients with early-stage, primary lung cancer or lung metastases.
Intended Guideline Users
Clinicians (radiologists, thoracic surgeons, medical and radiation oncologists, and respirologists) involved in the delivery of focal tumour ablation for lung cancer patients.
These research questions were developed to direct the search for available evidence on focal tumour ablation for early-stage primary lung cancer and lung metastases:
- What is the effectiveness of focal tumour ablation for the treatment of patients with early-stage primary lung cancer or lung metastases?
- What are the complications associated with focal tumour ablation for early-stage primary lung cancer or lung metastases?
- What patient populations are most likely to benefit from focal tumour ablation for early-stage primary lung cancer or lung metastases?